| 2017 | Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients | Lee, MH; Huang, CF; Lai, HC; Lin, CY; Dai, CY; Liu, CJ; Wang, JH; Huang, JF; Su, WP; Yang, HC; Kee, KM; Yeh, ML; Chuang, PH; Hsu, SJ; Huang, CI; Kao, JT; Chen, CC; Chen, SH; Jeng, WJ; Yang, HI; Yuan, Y; Lu, SN; Sheen, IS; Liu, CH; Peng, CY; Kao, JH; Yu, ML; Chuang, WL; Chen, CJ | Scientific reports 7, 3718 | | | |
| 2016 | HIP1 is an Early-stage Prognostic Biomarker of Lung Adenocarcinoma and Suppresses Metastasis via Akt-mediated EMT. | Hsu, CY; Lin, CH; Jan, YH; Su, CY; Yao, YC; Cheng, HC; Hsu, TI; Wang, PS; Su, WP; Yang, CJ; Huang, MS; Calkins, MJ; Hsiao, M; Lu, PJ | American Journal of Respiratory and Critical Care Medicine Apr 15;193(8):869-80 | | | |
